Maciej Kosiński
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maciej Kosiński has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alicja Nowik
Military Institute of Medicine, Szaserow 128, 04-141 Warsaw, Poland
4 shared publications - Igor Zydlewski
Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
4 shared publications - Marcin Sękulski
Medical University of Warsaw, Warsaw, Poland
4 shared publications - Martyna Mrozek
Faculty of Medicine, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
4 shared publications - Martyna Pacanowska-Trawnicka
Independent Public Healthcare Institution of the Ministry of the Interior and Administration, Cracow, Poland
4 shared publications - Małgorzata Blecharczyk
Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
4 shared publications
Latest Publications
- Open Access
- 20 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 46
Endometriosis as a Chronic Disease - Impact on Patients Quality of Life
Endometriosis is a chronic gynecological condition marked by the presence of endometrial-like cells outside the uterine cavity, most commonly affecting the ovaries, fallopian tubes, and peritoneum. Despite an estimated prevalence of 10% among women of reproductive age, the condition is often underdiagnosed and underrecognized. Many women endure years of symptoms before receiving an accurate diagnosis, resulting in prolonged physical suffering and significant disruption to daily life. Common symptoms include severe menstrual pain, dyspareunia, chronic pelvic pain, fatigue, and infertility. Due to their cyclical and persistent nature, these symptoms negatively affect women's physical and mental health, social functioning, relationships, and professional life. As there is no definitive cure and symptoms often recur, endometriosis is classified as a chronic illness requiring a comprehensive care approach. This paper explores the multifaceted impact of endometriosis on quality of life and examines key assessment tools such as SF-36, WHOQOL-BREF, and EHP-30. It also includes an overview of current treatment strategies - both pharmacological and surgical - as well as supportive and non-pharmacological approaches. The need for an individualized and multidisciplinary model of care is emphasized to improve outcomes and support the overall well-being of affected women.
- 20 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 46
Open AccessEndometriosis as a Chronic Disease - Impact on Patients Quality of Life
Endometriosis is a chronic gynecological condition marked by the presence of endometrial-like cells outside the uterine cavity, most commonly affecting the ovaries, fallopian tubes, and peritoneum. Despite an estimated prevalence of 10% among women of reproductive age, the condition is often underdiagnosed and underrecognized. Many women endure years of symptoms before receiving an accurate diagnosis, resulting in prolonged physical suffering and significant disruption to daily life. Common symptoms include severe menstrual pain, dyspareunia, chronic pelvic pain, fatigue, and infertility. Due to their cyclical and persistent nature, these symptoms negatively affect women's physical and mental health, social functioning, relationships, and professional life. As there is no definitive cure and symptoms often recur, endometriosis is classified as a chronic illness requiring a comprehensive care approach. This paper explores the multifaceted impact of endometriosis on quality of life and examines key assessment tools such as SF-36, WHOQOL-BREF, and EHP-30. It also includes an overview of current treatment strategies - both pharmacological and surgical - as well as supportive and non-pharmacological approaches. The need for an individualized and multidisciplinary model of care is emphasized to improve outcomes and support the overall well-being of affected women.
- Open Access
- 20 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 46
Psychological aspects of living with inflammatory bowel diseases
Inflammatory bowel diseases (IBD), encompassing Crohn’s disease and ulcerative colitis, are chronic, relapsing conditions that significantly impact not only patients’ physical health but also their psychological well-being. The disease course, characterized by alternating periods of remission and exacerbation, is associated with pain, diarrhea, fatigue, and the need for constant adaptation to fluctuating health status. Patients frequently experience depression, anxiety disorders, chronic stress, reduced self-esteem, and body image disturbances, particularly following surgical interventions. The disease exerts a profound influence on social, occupational, and family life, often resulting in isolation and stigmatization. This work underscores the importance of psychological support, including cognitive-behavioral therapy (CBT), acceptance and commitment therapy (ACT), and mindfulness-based interventions, all of which facilitate patients’ adaptation to living with a chronic illness. The integration of psychological care with medical treatment, the development of psychoeducational programs, and stigma-reduction initiatives are strongly recommended. A comprehensive approach that addresses both somatic and psychological dimensions is essential to improve the quality of life in patients with IBD. Further research is warranted to better understand the most effective psychological support strategies and their impact on disease outcomes.
- 20 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 46
Open AccessPsychological aspects of living with inflammatory bowel diseases
Inflammatory bowel diseases (IBD), encompassing Crohn’s disease and ulcerative colitis, are chronic, relapsing conditions that significantly impact not only patients’ physical health but also their psychological well-being. The disease course, characterized by alternating periods of remission and exacerbation, is associated with pain, diarrhea, fatigue, and the need for constant adaptation to fluctuating health status. Patients frequently experience depression, anxiety disorders, chronic stress, reduced self-esteem, and body image disturbances, particularly following surgical interventions. The disease exerts a profound influence on social, occupational, and family life, often resulting in isolation and stigmatization. This work underscores the importance of psychological support, including cognitive-behavioral therapy (CBT), acceptance and commitment therapy (ACT), and mindfulness-based interventions, all of which facilitate patients’ adaptation to living with a chronic illness. The integration of psychological care with medical treatment, the development of psychoeducational programs, and stigma-reduction initiatives are strongly recommended. A comprehensive approach that addresses both somatic and psychological dimensions is essential to improve the quality of life in patients with IBD. Further research is warranted to better understand the most effective psychological support strategies and their impact on disease outcomes.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
CLINICAL AND PATHOPHYSIOLOGICAL SPECIFICITIES OF ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES
Research objectives: Type 2 diabetes mellitus significantly increases the risk of developing atherosclerosis and cardiovascular complications. Cardiovascular diseases are the leading cause of death in this patient population; however, diagnosis is often delayed due to the potential for atypical clinical presentation. The purpose of this review is to present the specific clinical and pathophysiological features of atherosclerosis in patients with type 2 diabetes mellitus, with particular emphasis on the distinct mechanisms of atherosclerotic development in these patients, as well as diagnostic and prognostic differences. Key findings: In the course of type 2 diabetes mellitus, atherosclerosis develops against a background of chronic metabolic disturbances such as hyperglycemia, insulin resistance, dyslipidemia, and chronic inflammation. Patients often present with atypical or minimal symptoms, which complicates early diagnosis. Standard cardiovascular risk assessment tools may underestimate the actual threat in this group. Current research is exploring the use of novel biomarkers and imaging techniques to improve the precision of risk stratification. Summary (conclusions): Atherosclerosis in type 2 diabetes mellitus is characterized by a distinct clinical and biological profile. Understanding these differences is essential for earlier diagnosis, more accurate risk assessment, and more effective cardiovascular prevention in this high-risk patient population.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
Open AccessCLINICAL AND PATHOPHYSIOLOGICAL SPECIFICITIES OF ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES
Research objectives: Type 2 diabetes mellitus significantly increases the risk of developing atherosclerosis and cardiovascular complications. Cardiovascular diseases are the leading cause of death in this patient population; however, diagnosis is often delayed due to the potential for atypical clinical presentation. The purpose of this review is to present the specific clinical and pathophysiological features of atherosclerosis in patients with type 2 diabetes mellitus, with particular emphasis on the distinct mechanisms of atherosclerotic development in these patients, as well as diagnostic and prognostic differences. Key findings: In the course of type 2 diabetes mellitus, atherosclerosis develops against a background of chronic metabolic disturbances such as hyperglycemia, insulin resistance, dyslipidemia, and chronic inflammation. Patients often present with atypical or minimal symptoms, which complicates early diagnosis. Standard cardiovascular risk assessment tools may underestimate the actual threat in this group. Current research is exploring the use of novel biomarkers and imaging techniques to improve the precision of risk stratification. Summary (conclusions): Atherosclerosis in type 2 diabetes mellitus is characterized by a distinct clinical and biological profile. Understanding these differences is essential for earlier diagnosis, more accurate risk assessment, and more effective cardiovascular prevention in this high-risk patient population.
- Open Access
- 14 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39
How Does Creatine Supplementation Affect Physical Performance and Muscle Recovery? - A Literature Review of Its Effects, Mechanisms of Action, Safety and Side Effects
Introduction: Creatine is a naturally occurring compound that plays a primary role in energy metabolism, particularly within muscle cells. Its main sites of synthesis include the liver, kidneys, and pancreas [1,2]. This compound is crucial for muscle recovery following exercise. Creatine's ability to rapidly replenish ATP stores reduces fatigue and muscle soreness, thereby accelerating the recovery process. By increasing the availability of phosphocreatine in muscle cells, creatine significantly enhances the capacity to perform both short-duration and high-intensity exercises [4,8]. This allows athletes to complete more repetitions per set and recover faster between sets. Consequently, creatine supplementation has gained increasing popularity, particularly among athletes and physically active individuals. Additionally, creatine's influence on muscle protein synthesis is also linked to its ability to improve muscle cell hydration [15]. Aim of the Study: The aim of this study is to evaluate the impact of creatine supplementation on physical performance and muscle recovery, as well as to review its efficacy, safety, and potential side effects. Material and Methods: A review and analysis of randomized clinical trials and clinical studies from 2010 to 2025 available in PubMed and Google Scholar. Conclusions: Research findings indicate that long-term creatine use does not cause significant adverse side effects. Individuals supplementing with creatine have shown an increase in lean body mass without any undesirable effects on liver and kidney function. By improving muscle strength and endurance, creatine helps stabilize joints, thereby reducing the risk of musculoskeletal injuries [13]. From a practical perspective, these findings provide valuable insights for athletes, coaches, and physically active individuals striving to enhance both short-term and long-term training outcomes through creatine supplementation.
- 14 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39
Open AccessHow Does Creatine Supplementation Affect Physical Performance and Muscle Recovery? - A Literature Review of Its Effects, Mechanisms of Action, Safety and Side Effects
Introduction: Creatine is a naturally occurring compound that plays a primary role in energy metabolism, particularly within muscle cells. Its main sites of synthesis include the liver, kidneys, and pancreas [1,2]. This compound is crucial for muscle recovery following exercise. Creatine's ability to rapidly replenish ATP stores reduces fatigue and muscle soreness, thereby accelerating the recovery process. By increasing the availability of phosphocreatine in muscle cells, creatine significantly enhances the capacity to perform both short-duration and high-intensity exercises [4,8]. This allows athletes to complete more repetitions per set and recover faster between sets. Consequently, creatine supplementation has gained increasing popularity, particularly among athletes and physically active individuals. Additionally, creatine's influence on muscle protein synthesis is also linked to its ability to improve muscle cell hydration [15]. Aim of the Study: The aim of this study is to evaluate the impact of creatine supplementation on physical performance and muscle recovery, as well as to review its efficacy, safety, and potential side effects. Material and Methods: A review and analysis of randomized clinical trials and clinical studies from 2010 to 2025 available in PubMed and Google Scholar. Conclusions: Research findings indicate that long-term creatine use does not cause significant adverse side effects. Individuals supplementing with creatine have shown an increase in lean body mass without any undesirable effects on liver and kidney function. By improving muscle strength and endurance, creatine helps stabilize joints, thereby reducing the risk of musculoskeletal injuries [13]. From a practical perspective, these findings provide valuable insights for athletes, coaches, and physically active individuals striving to enhance both short-term and long-term training outcomes through creatine supplementation.
- Open Access
- 8 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39
Stem cell therapy in treatment of heart failure – a literature review
Introduction Heart failure is a condition defined as insufficient supply of oxygen to tissues, caused by a reduced cardiac output. It is usually associated with myocardial infarction or valve malfunction, but can also be a result of chronic diseases, such as hypertension or alcohol abuse. Despite the good state of knowledge about this disease and modern forms of treatment, heart failure remains a major therapeutic problem and a common cause of death around the world. The evolution of heart failure treatment over the years has revolved around managing the symptoms, yet failed to develop a causal treatment. Stem cell therapy has risen interest among researchers, as promising studies had emerged. The regenerative potential of stem cells and their paracrine properties are believed to improve cardiac function in patients with heart failure. Aim of study The aim of this study is to review randomized clinical trials published in the last 5 years and evaluate the safety and potential role of stem cell therapy in managing patients suffering from heart failure. State of knowledge Stem cells are capable of self-renewal and differentiating into other types of cells. They hold great promise in the field of regenerative medicine as a factor inducing tissue repair, reducing apoptosis and promoting angiogenesis. Animal studies have shown their positive effect on cardiac contractility and also reducing the amount of scar tissue, but subsequent studies in humans have not yielded consistent results. Conclusion Heart failure therapy using stem cells is a safe method. Promising results of clinical studies have been reported related to the improvement of contractile function of the heart, as well as reduction of scar mass and improvement of quality of life. However, there is still a lack of consistent data and guidelines regarding the selection of the type of cells and the method of their administration. This topic requires broader studies, on larger groups of patients.
- 8 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39
Open AccessStem cell therapy in treatment of heart failure – a literature review
Introduction Heart failure is a condition defined as insufficient supply of oxygen to tissues, caused by a reduced cardiac output. It is usually associated with myocardial infarction or valve malfunction, but can also be a result of chronic diseases, such as hypertension or alcohol abuse. Despite the good state of knowledge about this disease and modern forms of treatment, heart failure remains a major therapeutic problem and a common cause of death around the world. The evolution of heart failure treatment over the years has revolved around managing the symptoms, yet failed to develop a causal treatment. Stem cell therapy has risen interest among researchers, as promising studies had emerged. The regenerative potential of stem cells and their paracrine properties are believed to improve cardiac function in patients with heart failure. Aim of study The aim of this study is to review randomized clinical trials published in the last 5 years and evaluate the safety and potential role of stem cell therapy in managing patients suffering from heart failure. State of knowledge Stem cells are capable of self-renewal and differentiating into other types of cells. They hold great promise in the field of regenerative medicine as a factor inducing tissue repair, reducing apoptosis and promoting angiogenesis. Animal studies have shown their positive effect on cardiac contractility and also reducing the amount of scar tissue, but subsequent studies in humans have not yielded consistent results. Conclusion Heart failure therapy using stem cells is a safe method. Promising results of clinical studies have been reported related to the improvement of contractile function of the heart, as well as reduction of scar mass and improvement of quality of life. However, there is still a lack of consistent data and guidelines regarding the selection of the type of cells and the method of their administration. This topic requires broader studies, on larger groups of patients.
- Open Access
- 8 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39, 58919
Review of the Latest Therapeutic Approaches in the Management of Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a common and chronic bowel disease which, although it does not lead to severe and permanent complications, significantly deteriorates patients' quality of life. It constitutes a considerable psychological burden for them and also represents a significant socio-economic problem for the healthcare system. Although the cause of the disease is complex and still not fully understood, the update of the Rome criteria has led to significant progress in understanding the pathophysiology of the disease and researching alternative treatment methods. As a result, modern therapeutic approaches can be better tailored to the predominant symptoms and individual needs of the patient. This review compiles the latest research findings on the etiopathogenesis of the disease and discusses available therapeutic strategies, including options unavailable in Poland. This enables a better selection of effective therapy and achievement of satisfactory treatment outcomes through a more individualized approach, tailored to the patient's specific clinical profile.
- 8 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39, 58919
Open AccessReview of the Latest Therapeutic Approaches in the Management of Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a common and chronic bowel disease which, although it does not lead to severe and permanent complications, significantly deteriorates patients' quality of life. It constitutes a considerable psychological burden for them and also represents a significant socio-economic problem for the healthcare system. Although the cause of the disease is complex and still not fully understood, the update of the Rome criteria has led to significant progress in understanding the pathophysiology of the disease and researching alternative treatment methods. As a result, modern therapeutic approaches can be better tailored to the predominant symptoms and individual needs of the patient. This review compiles the latest research findings on the etiopathogenesis of the disease and discusses available therapeutic strategies, including options unavailable in Poland. This enables a better selection of effective therapy and achievement of satisfactory treatment outcomes through a more individualized approach, tailored to the patient's specific clinical profile.
- Open Access
- 6 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39, 58907
Is xylitol a sweet revolution? - A literature review of its metabolic effects and innovative applications
Introduction: Xylitol is a natural sweetener clasified as a sugar alcohol. It tastes and looks like sugar, but has a 40% lower caloric value. Sugar alcohols are becoming more popular not only in overweight or diabetic patients, but also in everyday life of young, athletic people. Xylitol has been studied since the 1960s for its antihyperglycemic, antiobesogenic and antidiabetic potential [1], and its health effects have been confirmed in many studies over the years, which is why they are often used in dental care products and chewing gums [2]. This polyol seems to be very promising in supporting treatment of various diseases. It is known that its metabolic effect is different from glucose metabolism, but the effects of xylitol on the body are still not fully understood, which creates a wide range of potential applications for xylitol. Aim of the study: The purpose of this study is to evaluate the influence of xylitol on human metabolism and to review innovative ideas of its use based on randomized clinical trials and clinical trails published in the last five years. Material and Methods: Review and analysis of randomised clinical trials and clinical trials from 2020-2025 available on PubMed and Google Scholar. Conclusions: Xylitol is definitely promising as an alternative sweetener. With its sweetness and slightly impact on postprandial glycemia it can be consumed as a sugar substitute, also in combination with a high protein meal. However, xylitol may gain much wider application than just a sweetener - by supporting the symptomatic treatment of gastroesophageal reflux disease (GERD) and good osmometabolic properties during peritoneal dialysis (PD), it seems to maintain the benefits of traditional therapies while avoiding side effects. Most of the studies published so far on innovative use of xylitol were pilot studies, therefore metabolic regulation, brain network modulation and general long-term impact of xylitol on health needs extensive studies.
- 6 March 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 39, 58907
Open AccessIs xylitol a sweet revolution? - A literature review of its metabolic effects and innovative applications
Introduction: Xylitol is a natural sweetener clasified as a sugar alcohol. It tastes and looks like sugar, but has a 40% lower caloric value. Sugar alcohols are becoming more popular not only in overweight or diabetic patients, but also in everyday life of young, athletic people. Xylitol has been studied since the 1960s for its antihyperglycemic, antiobesogenic and antidiabetic potential [1], and its health effects have been confirmed in many studies over the years, which is why they are often used in dental care products and chewing gums [2]. This polyol seems to be very promising in supporting treatment of various diseases. It is known that its metabolic effect is different from glucose metabolism, but the effects of xylitol on the body are still not fully understood, which creates a wide range of potential applications for xylitol. Aim of the study: The purpose of this study is to evaluate the influence of xylitol on human metabolism and to review innovative ideas of its use based on randomized clinical trials and clinical trails published in the last five years. Material and Methods: Review and analysis of randomised clinical trials and clinical trials from 2020-2025 available on PubMed and Google Scholar. Conclusions: Xylitol is definitely promising as an alternative sweetener. With its sweetness and slightly impact on postprandial glycemia it can be consumed as a sugar substitute, also in combination with a high protein meal. However, xylitol may gain much wider application than just a sweetener - by supporting the symptomatic treatment of gastroesophageal reflux disease (GERD) and good osmometabolic properties during peritoneal dialysis (PD), it seems to maintain the benefits of traditional therapies while avoiding side effects. Most of the studies published so far on innovative use of xylitol were pilot studies, therefore metabolic regulation, brain network modulation and general long-term impact of xylitol on health needs extensive studies.